Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IDELALISIB vs IDURSULFASE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IDELALISIB vs IDURSULFASE: Safety Overview

Metric IDELALISIB IDURSULFASE
Total FAERS Reports 6,862 3,188
Deaths Reported 1,548 526
Death Rate 22.6% 16.5%
Hospitalizations 2,962 1,734
Average Patient Age 70.0 yrs 13.2 yrs
% Female Patients 38.4% 1.1%
FDA Approval Date Jul 23, 2014 N/A
Manufacturer Gilead Sciences, Inc. Takeda Pharmaceuticals America, Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription